Barry R Smith

Title: Barry R. Smith: Innovator in Ophthalmic Pharmaceuticals

Introduction

Barry R. Smith is a notable inventor based in Corona Del Mar, California. He has made significant contributions to the field of ophthalmology, particularly in the development of pharmaceutical compositions aimed at treating eye conditions. His work is especially relevant in the context of glaucoma, a disease that affects millions worldwide.

Latest Patents

Barry R. Smith holds a patent for the "Topical ophthalmic use of Prazosin." This patent describes an ophthalmic composition that includes Prazosin or a pharmaceutically acceptable salt thereof, combined with a topically administrable ophthalmic pharmaceutical carrier. The composition is designed to lower intraocular pressure in the eye, which is crucial for the treatment of glaucoma. This innovative approach addresses a significant medical need, as elevated intraocular pressure is a primary concern in managing this condition.

Career Highlights

Barry R. Smith is associated with Allergan Pharmaceuticals, a leading company in the field of eye care and other therapeutic areas. His work at Allergan has allowed him to focus on developing effective treatments that improve patient outcomes. With a patent portfolio that includes 1 patent, he has demonstrated his commitment to advancing ophthalmic therapies.

Collaborations

Barry has collaborated with various professionals in the pharmaceutical industry, including his coworker David L. Murray. These collaborations have likely contributed to the successful development and implementation of innovative treatments in ophthalmology.

Conclusion

Barry R. Smith's contributions to ophthalmic pharmaceuticals, particularly through his patent on Prazosin, highlight his role as an innovator in the field. His work continues to impact the treatment of glaucoma, showcasing the importance of innovation in healthcare.